Open-label, Global, Multicenter, Randomized, Phase 3 Study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and anti-PD-1/PD-L1 Immunotherapy

Project: Research

Project Details

Project Description

Effective start/end date21/03/2220/03/27


  • Randomised clinical trial
  • multicentre trial
  • treatment safety
  • treatment efficacy
  • lung cancer